Researchers at the University of Rochester have done something that sounded impossible until now: they took a longevity gene from naked mole rats and put it into mice. The mice lived longer. They got sick less often. And they aged more slowly.
This isn't science fiction. It's a proof of concept that longevity mechanisms honed by nature over millions of years might actually be transferable to other mammals—possibly including us.
The molecule that changes aging
The key is a single molecule called hyaluronan, a gel-like substance that sits between cells and helps them communicate, repair damage, and handle stress. Naked mole rats produce an unusually large form of it—high molecular weight hyaluronic acid (HMW-HA)—and Vera Gorbunova's team suspected this might be why these animals live so long and rarely get cancer.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxTo test the idea, they introduced the naked mole rat version of the gene that makes HMW-HA into ordinary laboratory mice. The result was striking: the mice lived about 4.4 percent longer. But lifespan was almost beside the point. What mattered more was what happened during those extra years. The engineered mice showed better protection against tumors, less inflammation throughout their bodies, and healthier guts as they aged. They aged better, not just longer.
The distinction matters enormously. Hyaluronan's effects depend entirely on its size. The large form reduces inflammation and protects tissue. Smaller fragments, created when hyaluronan breaks down, can trigger inflammation and even support tumor growth. A future therapy can't just flood the body with hyaluronan—it has to preserve the right form.
Why naked mole rats are nature's outliers
Naked mole rats live 30 years in captivity, roughly nine times longer than similarly sized rodents. They almost never develop cancer. They're wrinkled and hairless and live underground in colonies like bees. And over the past decade, Gorbunova and her colleague Andrei Seluanov have traced much of their resilience to how they make and maintain hyaluronan.
Recent comparative work has found that other subterranean mammals also produce abundant HMW-HA, while their aboveground cousins typically don't. This suggests the mechanism may be part of a broader evolutionary toolkit for surviving long lives under harsh conditions—a strategy shaped by genes controlling both hyaluronan synthesis and the enzymes that break it down.
From gene transfer to something you might take
The researchers are clear: direct gene transfer won't be the path to human medicine. "It took us 10 years from discovering HMW-HA in the naked mole rat to showing it improves health in mice," Gorbunova says. "Our next goal is to transfer this benefit to humans."
They're pursuing two practical routes. One is to boost the body's own production of HMW-HA. The other is to slow the enzymes that break it down—a strategy that mirrors what naked mole rats appear to do naturally.
That second approach is already yielding candidates. In a 2024 study, the Rochester team screened thousands of compounds looking for hyaluronidase inhibitors. They found one: delphinidin, an anthocyanidin pigment found in blueberries, raspberries, and other fruits. In mice, delphinidin increased HMW-HA levels in tissues, reduced cancer cell migration, and suppressed melanoma spread. It's a small molecule from food that does what a gene transfer accomplishes.
The honest limits
It's important to say what this research doesn't claim. Boosting HMW-HA appears to shift aging toward a healthier trajectory—less cancer, less chronic inflammation, more resilient tissues—but it's unlikely to be a universal shield against all aspects of aging. A recent study found that mice with the naked mole rat gene showed improvements in late-life health but didn't protect against age-related hearing loss. Some organs may be less reachable by this pathway than others.
The broader insight is becoming testable: some longevity adaptations may be portable across species, but turning them into human medicine will require precision. The right molecular form of hyaluronan. The right balance between synthesis and breakdown. Careful monitoring for tradeoffs as different tissues respond differently.
The path forward is neither simple nor guaranteed. But it's now measurably clearer.
